Six national hospital associations recently urged the Supreme Court to correct what they called the Department of Health and Human [...] …
Category: Providers
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] …
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...] …
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] …
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...] …
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...] …
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...] …
AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to rural referral centers (RRC), sole [...] …
The Health Resources and Services Administration (HRSA) has requested public comment on how petitioners file their initial claims in the [...] …
Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...] …